Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.

Pringsheim T, Doja A, Gorman D, McKinlay D, Day L, Billinghurst L, Carroll A, Dion Y, Luscombe S, Steeves T, Sandor P.

Can J Psychiatry. 2012 Mar;57(3):133-43. Review.

PMID:
22397999
2.

Interventions for tic disorders: An overview of systematic reviews and meta analyses.

Yang C, Hao Z, Zhu C, Guo Q, Mu D, Zhang L.

Neurosci Biobehav Rev. 2016 Apr;63:239-55. doi: 10.1016/j.neubiorev.2015.12.013. Epub 2016 Jan 2. Review.

PMID:
26751711
3.

Treatment of multiple tics and the Tourette syndrome.

Gillies DR, Forsythe WI.

Dev Med Child Neurol. 1984 Dec;26(6):830-3. Review. No abstract available.

PMID:
6151532
4.

Pharmacological treatment of tic disorders and Tourette Syndrome.

Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, Münchau A.

Neuropharmacology. 2013 May;68:143-9. doi: 10.1016/j.neuropharm.2012.05.043. Epub 2012 Jun 20. Review.

PMID:
22728760
5.

Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis.

Hollis C, Pennant M, Cuenca J, Glazebrook C, Kendall T, Whittington C, Stockton S, Larsson L, Bunton P, Dobson S, Groom M, Hedderly T, Heyman I, Jackson GM, Jackson S, Murphy T, Rickards H, Robertson M, Stern J.

Health Technol Assess. 2016 Jan;20(4):1-450, vii-viii. doi: 10.3310/hta20040. Review.

6.

Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.

Egolf A, Coffey BJ.

Drugs Today (Barc). 2014 Feb;50(2):159-79. doi: 10.1358/dot.2014.50.2.2097801. Review.

PMID:
24619591
7.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
8.

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

Rizzo R, Gulisano M, Calì PV, Curatolo P.

Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Epub 2013 Mar 7. Review.

PMID:
23473832
9.

Tourette syndrome: clinical characteristics and current management strategies.

Kossoff EH, Singer HS.

Paediatr Drugs. 2001;3(5):355-63. Review.

PMID:
11393328
10.

Pharmacologic treatment of tic disorders.

Scahill L, Chappell PB, King RA, Leckman JF.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):99-117. Review.

PMID:
10674192
11.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

12.

Pharmacotherapy of Tourette's syndrome and associated disorders.

Cohen DJ, Riddle MA, Leckman JF.

Psychiatr Clin North Am. 1992 Mar;15(1):109-29. Review.

PMID:
1549543
13.

Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.

Pringsheim T, Steeves T.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007990. doi: 10.1002/14651858.CD007990.pub2. Review.

PMID:
21491404
14.

Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment.

Singer HS, Gammon K, Quaskey S.

Pediatr Neurosci. 1985-1986;12(2):71-4.

PMID:
3870139
15.

Recent advances in the management of tics.

Jankovic J.

Clin Neuropharmacol. 1986;9 Suppl 2:S100-10. Review. No abstract available.

PMID:
2885086
16.

Pharmacological management of tics in patients with TS.

Sandor P.

J Psychosom Res. 2003 Jul;55(1):41-8. Review.

PMID:
12842230
17.

Pharmacologic therapy of tics in childhood.

Erenberg G.

Pediatr Ann. 1988 Jun;17(6):395-404. No abstract available.

PMID:
3164466
18.

Predictors of clonidine response in Tourette syndrome: implications and inferences.

Lichter DG, Jackson LA.

J Child Neurol. 1996 Mar;11(2):93-7.

PMID:
8881983
19.

European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ; ESSTS Guidelines Group.

Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96. doi: 10.1007/s00787-011-0163-7. Erratum in: Eur Child Adolesc Psychiatry. 2011 Jul;20(7):377.

20.

Pharmacological options for the treatment of Tourette's disorder.

Jiménez-Jiménez FJ, García-Ruiz PJ.

Drugs. 2001;61(15):2207-20. Review.

PMID:
11772131

Supplemental Content

Support Center